Stock Report

Venus Remedies Ltd consolidated Q2FY22 profit jumps to Rs. 23.14 crore

Posted On : 2021-11-04 22:00:17( TIMEZONE : IST )

Venus Remedies Limited has reported Consolidated financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 205.45 crores during the period ended September 30, 2021 as compared to Rs. 131.765 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. 23.148 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 11.697 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 17.32 for the period ended September 30, 2021 as compared to Rs. 8.86 for the period ended June 30, 2021.

Financials	Q2 FY2022	Q1 FY2022	% Change
Total Income	₹ 205.45 crs	₹131.765 crs	55.92%
Net Profit	₹23.148 crs	₹11.697 crs	97.90%
EPS	₹17.32	₹8.86	95.49%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 205.45 crores during the period ended September 30, 2021 as compared to Rs.138.345 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.23.148 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.13.026 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.17.32 for the period ended September 30, 2021 as compared to Rs.10.55 for the period ended September 30, 2020.

Financials	Q2 FY2022	Q2 FY2021	% Change
Total Income	₹ 205.45 crs	₹138.345 crs	48.51%
Net Profit	₹23.148 crs	₹13.026 crs	77.71%
EPS	₹17.32	₹10.55	64.17%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.337.215 crores during the 6 Months period ended September 30, 2021 as compared to Rs.329.125 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.34.846 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.14.999 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.26.41 for the 6 Months period ended September 30, 2021 as compared to Rs.12.15 for the 6 Months period ended September 30, 2020.

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹337.215 crs	₹329.125 crs	2.46%
Net Profit	₹34.846 crs	₹14.999 crs	132.32%
EPS	₹26.41	₹12.15	117.37%

Shares of Venus Remedies Limited was last trading in BSE at Rs. 525.65 as compared to the previous close of Rs. 544.90. The total number of shares traded during the day was 12799 in over 863 trades.

The stock hit an intraday high of Rs. 544.95 and intraday low of 520.10. The net turnover during the day was Rs. 6752694.00.